The irregular response to progestins directly in tumor growth might be caused by dominant negative progesterone receptor (PR) mutants and the damage to PR-A expression. Progestin treatment as an anti-angiogenic therapy would be less effective in the PR-mutated tumors. Therefore, various anti-angiogenic inhibitors must be used in progestin-refractory and progestin-dependent tumors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000055276 | DOI Listing |
Publication Analysis
Top Keywords
tumor growth
8
progestin regulation
4
regulation tumor
4
growth female
4
female genital
4
genital tract
4
tract cancers
4
cancers irregular
4
irregular response
4
response progestins
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!